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The functionalized beta-diketones are clinically important
molecules showing antibacterial (Bennett et al. 1999; Sheikh
et al., 2009a,b), antiviral (Diana et al., 1978), insecticidal
(Crouse et al., 1989), antioxidant (Nishiyama et al., 2002),
potential prophylactic antitumor (Acton et al., 1980), anti-
sunscreen activity (Andrae et al., 1997), and more important
they proven to be an important pharmacophore of HIV-1
Integrase (IN) inhibitors (Tchertanov and Mouscadet, 2007).
Many biologically active compounds used as drugs
possess modiﬁed pharmacological and toxicological potentials
when administered in the form of metal-based compounds
(Timerbaev et al., 2006; Louie and Meade, 1999; Ming,
2003; Ming and Epperson, 2002). Many metallic elements
play a crucial role in living systems. A characteristic of metals
is that they easily lose electrons from the familiar elemental
or metallic state to form positively charged ions, which tend
to be soluble in biological ﬂuids. It is in this cationic form
that metals play their role in biology. Whereas metal ions
are electron deﬁcient, most biological molecules such as pro-
teins and DNA are electron rich. The attraction of these
opposing charges leads to a general tendency for metal ions
to bind to and interact with biological molecules. This same
principle applies to the afﬁnity of metal ions for many small
molecules and ions crucial to life, such as O2. Given this wide
scope for the interaction of metals in biology, it is not sur-
prising that natural evolution has incorporated many metals
into essential biological functions. Metals perform a wide
variety of tasks such as carrying oxygen throughout the body
and shuttling electrons. Hemoglobin, an iron-containing
protein that binds to oxygen through its iron atom, ferries
this vital molecule to body tissues. Metal ions such as zinc
provide the structural framework for the zinc ﬁngers that reg-
ulate the function of genes in the nuclei of cells. Similarly,
calcium-containing minerals are the basis of bones, the struc-
tural framework of the human body. Zinc is a natural
component of insulin, a substance crucial to the regulation
of sugar metabolism. Metals such as copper, zinc, iron, and
manganese are incorporated into catalytic proteins the metal-
loenzymes which facilitate a multitude of chemical reactions
needed for life (Solomon et al., 1996). Since nature has made
such extensive use of metal ions in biological systems, the
following questions arise: ‘‘Can metal ions be incorporated
into drugs? Are coordination compounds potential medi-
cinal agents? Can coordination chemistry be used for
medicinal purpose?’’ We term this area of scientiﬁc inquiry
medicinal inorganic chemistry – it is the subject of this
research article.
Various metal ions potentially and commonly used are co-
balt, copper, nickel and zinc because of forming low molecular
weight complexes and therefore, prove to be more beneﬁcial
against several diseases (Brown et al., 1980; Ruiz et al., 1995;
Castillo-Blum and Barba-Behrens, 2000). Various biological
aspects of the metal-based drugs/ligands entirely depend onthe ease of cleaving the bond between the metal ion and the
ligand. As a consequence, it is essential to understand the rela-
tionship between ligand and the metal in biological systems.
To further explore the clinical signiﬁcances of beta-diketones,
we have undertaken a task to synthesize and use them as a
potential candidate for metal complexation with Co(II), Ni(II),
Cu(II), Zinc(II) metal atom to form their corresponding
complexes (1)–(8) (Scheme 1) with the hope that these com-
pounds would potentially smart down mechanism of bacterial
resistance. The newly synthesized beta-diketone and their me-
tal complexes were characterized by IR, 1H NMR, 13C NMR,
molar conductance, magnetic moments, electronic and elemen-
tal analyses data. The synthesized ligand and transition metal
chelates have been screened for in vitro antibacterial activity
againstStaphylococcus aureus,Bacillus subtilis,Escherichia coli,
Pseudomonas aeruginosa and antifungal activity against
Candida albicans and Candida glabrata strains. In vitro free
radical scavenging activities of the ligand (L1)–(L2) and metal
chelates (1)–(8) were evaluated by DPPH assay method.2. Chemistry
The functionalized b-diketones 1-(20,40-dihydroxyphenyl)-3-
(200-substitutedphenyl)-propane-1,3-dione (L1)–(L2) have been
prepared by Baker–Venkataraman transformation of 2,4-dia-
royloxyacetophenones in dimethyl sulfoxide (DMSO) with
NaOH. The transition metal complexes (1)–(8) have been syn-
thesized by reﬂuxing the ethanolic solution of (L1)–(L2) with
metal salts for half an hour (Scheme 1).3. In vitro biological activity
3.1. Antimicrobial activity
In this research work Co(II), Ni(II), Cu(II) and Zinc(II) metal
complexes of 1-(20,40-dihydroxyphenyl)-3-(200-substitutedphenyl)-
propane-1,3-dione have been prepared to explore their anti-
bacterial, antifungal and antioxidant properties. The minimal
inhibitory concentrations (MICs, mg ml1) of tested com-
pounds against certain bacteria are shown in Tables 1 and 2.
The ligands (L1)–(L2) and metal complexes (1)–(8) were pre-
pared and tested for their in vitro antimicrobial activity against
the four strains of bacteria (gram negative and gram positive),
and two strains of fungi (C. albicans and C. glabrata). Some
metal complexes of the functionalized beta-diketones showed
high in vitro antimicrobial activity. The Cu(II) metal complex
(3) of (L1) showed excellent antibacterial activity against
E. coli and P. aeruginosa compared to Ampicillin, and excel-
lent antifungal activity against C. albicans comparable to
slightly lower than Fluconazole. Zinc(II) metal complex (4)
of (L1) showed excellent antibacterial activity against
E. coli comparable to Ampicilline and excellent antifungal
activity against C. glabrata comparable to slightly lower than
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Scheme 1 Preparation of functionalized beta-diketones (L1)–(L2) and their metal (II) complexes (1)–(8).
Table 1 Antibacterial activity of ligands (L1)–(L2) and metal complexes (1)–(8). Minimum inhibitory concentrations (MICs, mg/ml).
Compound Antibacterial activitya
S. aureus ATCC 25923 B. subtilis ATCC 6633 E. coli ATCC 27853 P. aeruginosa ATCC 27853
L1 0.625 0.15 1.25 0.3
L2 0.15 1.25 0.019 0.15
1 0.15 1.25 1.25 0.3
2 0.625 0.625 1.25 1.25
3 0.15 0.3 0.019 0.019
4 0.15 0.15 0.019 0.15
5 0.3 1.25 0.15 0.15
6 0.625 0.3 0.15 0.3
7 0.15 0.15 0.019 0.15
8 0.019 1.25 0.019 0.019
Ampicillin 0.019 0.005 0.01 0.005
a Antibacterial activity: In present protocol 1.25 mg ml1 is considered as moderate activity, 0.07 mg ml1 is considered as good activity and
0.019 is considered as excellent activity compared to the standard drug Ampicillin.
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antifungal activity against C. glabrata comparable to slightly
lower than Fluconazole. Zn(II) metal complex (7) of (L2)
showed excellent antibacterial activity against E. coli com-
pared to Ampicillin, and excellent antifungal activity against
C. albicans comparable to slightly lower than Fluconazole.
Zn(II) metal complex (8) of (L2) showed excellent antibacterial
activity against S. aureus, E. coli and P. aeruginosa comparedto Ampicillin, and excellent antifungal activity against C. albi-
cans and C. glabrata comparable to slightly lower than Fluco-
nazole. The presence of electron-withdrawing chloro group on
the aromatic ring in general increases the antimicrobial activi-
ties of the tested metal complexes compared to complexes hav-
ing no substituent.
These results suggested that metal complexes had effective
improvement of bioavailability, and electron-withdrawing
Table 2 Antifungal and antioxidant activity of ligands (L1)–(L2) and metal complexes (1)–(8). Minimum inhibitory concentration
(MICs, mg/ml).
Compound Antifungal activitya Antioxidant Activity
C. albicans ATCC 10231 C. glabrata ATCC 36583 DPPH % Inhibition antioxidant
L1 2.5 2.5 84.34
L2 5.0 2.5 89.19
1 5.0 2.5 88.11
2 2.5 2.5 87.52
3 0.15 2.5 84.34
4 2.5 0.15 89.19
5 5.0 2.5 89.19
6 2.5 0.15 81.11
7 0.15 2.5 84.34
8 0.15 0.15 90.00
Fluconazole 0.01 0.01 –
Ascorbic acid – – 98.03
a Antifungal activity: In present protocol 0.15 mg ml1 is considered as excellent activity compared to the standard drug Fluconazole.
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microbial activities against both bacteria and fungi. The results
of antibacterial and antifungal activities are given in Tables 1
and 2.
3.2. Antioxidant activity
Table 2 summarizes free radical scavenging activity (antioxi-
dant activity) using the DPPH assay method. According these
results, the newly synthesized metal complexes had more
promising antioxidant activities than the ligands, and may
eventually be used as good antioxidant agents.4. Results and discussion
All the synthesized transition metal complexes of 1-(20,40-dihy-
droxyphenyl)-3-(200-substitutedphenyl)-propane-1,3-dione (L1)–
(L2) were soluble in dioxane, dimethylformamide and dimethyl
sulfoxide. The composition of which are in consistent with
their analytical and mass spectral data. The metal complexes
(1)–(8) were obtained by stoichiometric reaction of the corre-
sponding ligand with the transition metal salt in a molar ratio
M:L of 1:2. All the complexes were found to be thermally sta-
ble. They were insoluble in common organic solvents. Physical
measurements and analytical data of the transition complexes
(1)–(8) are given in experimental section.
4.1. Spectroscopic characterization of ligand (L1)–(L2) and
their transition metal complexes (1)–(8)
4.1.1. IR spectra
The characteristic infrared spectral assignment of ligands (L1)–
(L2) and their Co(II), Ni(II), Cu(II) and Zinc(II) complexes are
reported in experimental section. The presence of broad band
at 3320 cm1 in the spectra of the functionalized beta-diketone
(L1) exhibited due to –OH group. The appearance of a strong
band at 1743 cm1 in the spectra of ligand is assigned to car-
bonyl group (C‚O) and 1142 cm1 due to (C–O) stretch.
The band appearing at 1743 cm1 in the spectra of ligand
assigned to carbonyl group (C‚O) and 1142 cm1 due to
(C–O) stretch, exhibited a lower shift of 10–20 cm1 (1723–1733 and 1122–1133 cm1) in metal complexes (1)–(4). This
shift indicates that the beta-diketo functionality in ligand
(L1) coordinated with the transition metal ion. All the above
evidences were further supported by the emergence of new
bands at 520–532 and 445–460 cm1 due to metal–oxygen
vibrations. These new bands were only observed in the spectra
of the transition metal complexes and not in its ligands. As a
conclusion, comparison of the spectra of the ligand (L1) and
their metal complexes (1)–(4) conﬁrmed the coordination of li-
gand with the corresponding metal ion, bidentately through
beta-diketo functionality. The metal complexes (5)–(8) of li-
gand (L2) shows the same lowering of the stretching frequen-
cies as shown by the metal complexes (1)–(4) of ligand (L1).4.1.2. 1H NMR spectra
The 1H NMR spectral data of the 1-(20,40-dihydroxyphenyl)-3-
phenyl-propane-1,3-dione (L1) and their transition metal
complexes (1)–(4) are provided in the experimental part. The
displayed signals of all the protons of free ligands due to
aromatic groups were found as to be in their expected region.
The 1H NMR spectrum of ligand (L1) exhibited a singlet at d
15.72 ppm due to enolic proton, a singlet at d 12.02 ppm due to
phenolic proton adjacent to the carbonyl group, a singlet at d
4.76 ppm corresponds to the phenolic proton away from car-
bonyl group, a singlet at d 8.41 ppm (s, 1H, CH‚), and some
multiplets at d 6.48–7.47 ppm. The coordination of the beta-
diketo functionality is assigned by the downﬁeld shifting of
the (–CH‚) from d 8.41 ppm in free ligand to d 8.78–
8.88 ppm in its transition metal complexes (Silverstein et al.,
2005). The enolic proton at d 15.72 ppm in the ligand (L1) dis-
appeared in the spectra of all its metal complexes (1)–(4) indi-
cating deprotonation and coordination of the oxygen with the
metal ion. All other protons underwent downﬁeld shift by
0.15–0.30 ppm due to the increased conjugation (Ballhausen
and Gray, 1963) on complexation with the transition metal
atom. The same thing can be explained for the metal
complexes (5)–(8) of (L2).
4.1.3. 13C NMR spectra
The 13C NMR spectra of the free ligand and their transition
metal chelates were done in DMSO-d6. The
13C NMR spectral
Table 3 Conductivity, magnetic and spectral data of metal
(II) complexes (1)–(8).
Metal complexes XM (X
1 cm2 mol1) BM (leﬀ) kmax (cm
1)
1 17.9 2.18 654, 484
2 16.4 Dia 620
3 15.5 1.76 628
4 14.7 Dia 348.8
5 17.2 2.24 622, 460
6 16.8 Dia 591
7 15.8 1.90 610
8 14.8 Dia 346.5
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experimental section and all the carbons were found in the ex-
pected regions (Pasto, 1969). The conclusion obtained from this
study provides further support to the mode of bonding ex-
plained in IR and 1H NMR spectral data. The carbonyl carbon
(C‚O) and enolic carbon (C–O) of the ligand (L1) appeared in
the region d 189.8–190.1 ppm and d 184.9–185.3 ppm, respec-
tively. The methine linkage appeared in the region d 94.0–
94.2 ppm. The aromatic carbons of the free ligand were found
in the region at d 104.5–165.7 ppm. Downﬁeld shifting of the
carbonyl carbon (C‚O) and enolic carbon (C–O) from d
189.8–190.1 ppm and d 184.9–185.3 ppm in the free ligand
(L1) to d 190.4–191.2 ppm and d 185.6–186.1 ppm in its metal
(II) complexes (1)–(4) conﬁrmed coordination of the carbonyl
(C‚O) and enolic group (C–OH) to the transition metal atom.
Furthermore, the presence of the number of carbons agrees well
with their expected values. The same trend was observed for the
ligand (L2) and its metal complexes (5)–(8). The formations of
the ligands and metal complexes were also conﬁrmed by their
mass spectral data given in the experimental section.
4.1.4. Conductance, magnetic susceptibility and electronic
spectra of Co(II), Ni(II), Cu(II) and Zn(II) complexes
The molar conductance values were obtained in X1 cm2 mol1
at room temperature using DMF as a solvent and results are
recorded in Table 3. The complexes (1)–(8), showed their molar
conductance values in the ranges 12.8–16.6 X1 cm2 mol1
indicating their non-electrolytic nature (Geary, 1971).
The cobalt(II) complexes show magnetic moment in the
range 2.18–2.24 B.M. indicating that these complexes have a
low spin square planar conﬁguration (Warad et al., 2000).
Ni(II) complexes are diamagnetic, which indicates a low-
spin-state Ni center characteristic of square planar complexes
of Ni(II). The Cu(II) complexes are paramagnetic. For the
Cu(II) complexes (3) and (7), the leff values (at 302 K) are
in the range 1.76–1.90 B.M., which are slightly higher than
those expected for a d9 system (1.73 B.M.) and may be due
to the incomplete quenching of orbital contribution to the
magnetic moment or due to spin–orbit coupling. The room
temperature magnetic moment values of Zn(II) complexes
are found to be diamagnetic as expected due to non-availabil-
ity of unpaired electrons.
The electronic spectra of cobalt complexes showed a band
in the 654–622 nm region which can be assigned to
2A1gﬁ 2B1g. Another high intensity band in the 484–460 nm
region was also observed which may be due to charge transfer
transitions (Lever, 1974). The electronic spectra of the nicke-l(II) complexes showed a band in the 620–591 nm region due
to the 1A1gﬁ 1A2g transition arising from a square planar
geometry (Marpadga et al., 1996). The electronic spectra of
Cu(II) complexes showed a band in the 628–610 nm region
which may be attributed to the 2B1gﬁ 2A1g transition, as
expected for a square planar geometry (Mishra et al., 2002;
Mandlik et al., 2003).
The diamagnetic Zn(II) chelates did not show any d–d tran-
sition and their spectra were dominated only by the charge
transfer band at 348.8–346.5 nm. The electronic spectral values
of all complexes (1)–(8) were recorded in Table 3.
4.1.5. Thermogravimetric study of some metal complexes
Thermal gravimetric analysis of Cobalt complex (1). Cobalt
complex (1) shows some loss of weight up to 100 C due to
presence of surface water and up to 150 C due to presence
of lattice water (Mishra et al., 2002; Mandlik et al., 2003).
It further shows a weight loss between 165 and 200 C due
to two coordinated water molecules (calc. 5.99%, obs.
5.36%). A sudden weight loss from 225 C to 310 C due
to loss of one phenyl ring with two hydroxy and one
carbonyl group (calc. 23.13%, obs. 23.55%). Further, the
weight loss from 310 C to 585 C corresponds to the decom-
position of two phenyl ring and a propane-1,3-dione moiety
of the ligand (calc. 37.43%, obs. 37.58%). On further heating
up to 905 C the weight remaining corresponds to that of
CoO shows oxidation of the complex (calc. 12.43%, obs.
12.01%).
Thermal gravimetric analysis of nickel complex (2): In nick-
el complex (2), the initial weight loss is up to 100 C due to the
presence of surface water and 150 C due to the presence of lat-
tice water. There was a signiﬁcant loss of weight up to 200 C
observed due to two coordinated water molecules (calc. 5.92%,
obs. 5.02%). It further shows a weight loss from 270 C to
300 C due to the loss of two hydroxyl groups (calc. 5.75%,
obs. 6.11%) and weight loss between 315 C to 480 C due
to complete decomposition of one ligand (calc. 35.01%, obs.
34.01%). The weight loss from 510 C to 810 C corresponds
to the loss of two phenyl rings of second ligand (calc.
25.95%, obs. 25.08%). The weight remaining at the end i.e.,
at 915 C corresponds to formation of stable NiO (calc.
14.07%, obs. 14.98%).
Thermal gravimetric analysis of cobalt complex (5). Initial
weight loss up to 100 C and 150 C indicates the presence of
surface water and lattice water, respectively. The weight loss
up to 200 C shows the presence of two water molecules of
coordination (calc. 5.37%, obs. 5.14%). The TG curve shows
a sharp drop in weight from 210 C to 700 C that corresponds
to the loss of almost all the four aromatic rings of both ligands
(calc. 68.01%, obs. 68.96%). Finally the complex is oxidized to
CoO up to 900 C (calc. 15.00%, obs. 15.89%).
Thermal gravimetric analysis of nickel complex (6). The
complex shows some loss of weight up to 100 C and up to
150 C due to the presence of surface water and lattice water,
respectively. It further shows a weight loss up to 200 C due to
one coordinated water molecule (calc. 2.68%, obs. 2.24%).
The weight loss was between 215 C to 435 C due to the loss
of all the four phenyl rings of both the ligands (calc. 23.28%,
obs. 23.23%). The weight remaining at the end up to 930 C
corresponds to nickel oxide fraction (calc. 19.01%, obs.
19.75%).
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It has been suggested that the antibacterial, antifungal and
antioxidant activity of ligands (L1)–(L2) increased upon che-
lation/coordination with the transition of metal atoms. The
chelation process reduces the polarity of metal ion by coordi-
nating with ligands, which increase the lipophilic nature of
the metals. This lipophilic nature of the metal enhanced its
penetration through the lipoid layer of cell membrane of
the microorganism. Further, it has been suggested that func-
tionalized beta-diketone system having combined two or
more pharmacophore sites present in these compounds
played an important role in antibacterial, antifungal and anti-
oxidant activity. This functionalized system may be responsi-
ble for the enhancement of hydrophobic character and
liposolubility of the molecules.6. Experimental protocol
6.1. Material and methods
All chemicals used were of reagents grade. All metal salts were
used as chloride. Melting points were recorded on Fisher Johns
melting point apparatus. Infrared spectra were recorded on
SHIMADZU FT-IR spectrometer. The C, H and N analyses
were carried out using a Perkin Elmer, USA model. The 1H
and 13C NMR spectra were recorded in DMSO-d6 using
TMS as internal standard on a Bruker Spectrospin Avance
DPX-500 spectrometer. Electron impact mass spectra (EIMS)
were recorded on JEOL MS Route Instrument.
6.2. General procedure for the synthesis of beta-diketone (L1)–
(L2) and metal complexes (1)–(8)
6.2.1. General procedure for the synthesis of beta-diketone
(L1)–(L2)
The 2,4-diaroyloxyacetophenone was dissolved in 4 ml of
DMSO. To the solution powdered NaOH (1 g) was added with
vigorous stirring for about 5 min. The stirring was continued
further for about 5 min. The reaction mixture was then cooled
and poured on cold water. The pale yellow solid product ob-
tained was washed with water and ﬁltered off. It was crystal-
lized from alcohol.
6.2.1.1. 1-(20,40-Dihydroxyphenyl)-3-phenyl-propane-1,3-dione
(L1). Yield 67%; m.p. 158 C; FT-IR (KBr): 3420 (OH), 1743
(C‚O), 1598 (aromatic C‚C), 1142 (C–O); 1H NMR
(DMSO-d6, d, 300 MHz) 15.72 (s, 1H, enolic OH), 12.02 (s,
1H, 20-OH), 4.76 (s, 1H, 40-OH), 8.41 (s, 1H, –CH‚), 7.39 (d,
2H, J200–600 = 8.4 Hz, 2
00-H, 600-H), 6.48–7.47 (m, 5H, Ar-H),
6.39 (s, 30-H, Ar-H); 13C NMR (DMSO-d6, d, 300 MHz) 189.8
(s, C-1, C‚O), 184.9 (s, C-3), 94 (s, C-2, –CH‚), 115.4 (s, C-
10), 163.2 (s, C-20), 104.5 (s, C-30), 165.7 (s, C-40), 109 (s, C-50),
132.7 (s, C-60), 130.4 (s, C-100), 126.4 (s, C-200, C-600), 128.7 (s,
C-300, C-500), 128 (s, C-400). Anal. Calcd. for C15H12O4 (M
+):
(256) C, 70.31; H, 4.72. Found: C, 70.55; 4.91.
6.2.1.2. 1-(20,40-Dihydroxyphenyl)-3-(200-chlorophenyl)-pro-
pane-1,3-dione (L2). Yield 70%; m.p. 151 C; FT-IR (KBr):
3417 (OH), 1738 (C‚O), 1599 (aromatic C‚C), 1144(C–O); 1H NMR (DMSO-d6, d, 300 MHz) 15.79 (s, 1H, enolic
OH), 12.00 (s, 1H, 20-OH), 4.79 (s, 1H, 40-OH), 8.49 (s, 1H, –
CH‚), 6.41–7.39 (m, 6H, Ar-H), 6.33 (s, 30-H, Ar-H); 13C
NMR (DMSO-d6, d, 300 MHz) 189.7 (s, C-1, C‚O), 185.9
(s, C-3), 93 (s, C-2, –CH‚), 115.3 (s, C-10), 163.4 (s, C-20),
104.1 (s, C-30), 165.2 (s, C-40), 109.4 (s, C-50), 133.1 (s, C-60),
131.7 (s, C-100), 131.2 (s, C-200), 128.8 (s, C-300), 129.4 (s, C-
400), 126.8 (s, C-500), 130.2 (s, C-600). Anal. Calcd. for
C15H11ClO4 (M
+): (290) C, 61.98; H, 3.81. Found: C, 62.09;
3.97.
6.2.2. General procedure for preparation of transition metal
complexes (1)–(8)
A mixture of 5 mmol of 1-(20,40-dihydroxyphenyl)-3-(200-substi-
tutedphenyl)-propane-1,3-dione and 2.5 mmol of appropriate
transition metal chloride [Co(II), Ni(II), Cu(II), Zinc(II)] and
50 ml of anhydrous ethanol was stirred at 50–60 C for 3 h.
The colored solid complex obtained was washed with ethanol
and then with ethyl acetate. The yield was obtained in 69–75%.
The corresponding metal complexes were crystallized by
dichloromethane.
6.2.2.1. Bis[1-(20,40-dihydroxyphenyl)-3-phenyl-propane-1,3-
dionate]Co(II) complex (1). Dark orange, yield 65%, FT-
IR (KBr): 3416 (OH), 1732 (C‚O), 1599 (aromatic C‚C),
1133 (C–O); 1H NMR (DMSO-d6, 300 MHz,) d: 12.00 (s,
2H, 20-OH), 4.71 (s, 2H, 40-OH), 8.35 (s, 2H, –CH‚), 6.40–
7.39 (m, 16H, Ar-H); 13C NMR (DMSO-d6, 300 MHz,) d:
190.7 (s, C-1, C‚O), 185.2 (s, C-3), 94.3 (s, C-2, –CH‚),
115.7 (s, C-10), 163.9 (s, C-20), 105.1 (s, C-30), 165.9 (s, C-
40), 109.5 (s, C-50), 131.2 (s, C-60), 130.9 (s, C-100), 126.7 (s,
C-200, C-600), 129.4 (s, C-300, C-500), 128.6 (s, C-400). Anal. Calcd.
for C30H22CoO8 (M
+): (569) C, 63.28; H, 3.89. Found: C,
68.32; 3.92.
6.2.2.2. Bis[1-(20,40-dihydroxyphenyl)-3-phenyl-propane-1,3-
dionate]Ni(II) complex (2). Yellow, yield 67%, FT-IR (KBr):
3419 (OH), 1735 (C‚O), 1600 (aromatic C‚C), 1137 (C–O);
1H NMR (DMSO-d6, 300 MHz,) d: 12.01 (s, 2H, 20-OH), 4.69
(s, 2H, 40-OH), 8.31 (s, 2H, –CH‚), 6.39–7.31 (m, 16H, Ar-
H); 13C NMR (DMSO-d6, 300 MHz,) d: 190.5 (s, C-1, C‚O),
185.4 (s, C-3), 94.5 (s, C-2, –CH‚), 115.9 (s, C-10), 164.5 (s,
C-20), 105.5 (s, C-30), 166.3 (s, C-40), 109.8 (s, C-50), 131.6 (s,
C-60), 131.1 (s, C-100), 126.8 (s, C-200, C-600), 129.7 (s, C-300, C-
500), 129.4 (s, C-400). Anal. Calcd. for C30H22NiO8 (M
+): (568)
C, 63.30; H, 3.90. Found: C, 68.34; 3.94.
6.2.2.3. Bis[1-(20,40-dihydroxyphenyl)-3-phenyl-propane-1,3-
dionate]Cu(II) complex (3). Brick red, yield 68%, FT-IR
(KBr): 3421 (OH), 1729 (C‚O), 1598 (aromatic C‚C), 1134
(C–O); 1H NMR (DMSO-d6, 300 MHz,) d: 11.98 (s, 2H, 20-
OH), 4.61 (s, 2H, 40-OH), 8.29 (s, 2H, –CH‚), 6.32–7.34 (m,
16H, Ar-H); 13C NMR (DMSO-d6, 300 MHz,) d: 190.2 (s, C-
1, C‚O), 185.5 (s, C-3), 94.9 (s, C-2, –CH‚), 115.7 (s, C-10),
164.8 (s, C-20), 105.7 (s, C-30), 166.6 (s, C-40), 109.7 (s, C-50),
131.9 (s, C-60), 131.3 (s, C-100), 126.5 (s, C-200, C-600), 129.8 (s,
C-300, C-500), 129.5 (s, C-400). Anal. Calcd. for C30H22CuO8
(M+): (573) C, 62.77; H, 3.86. Found: C, 62.79; 3.89.
6.2.2.4. Bis[1-(20,40-dihydroxyphenyl)-3-phenyl-propane-1,3-
dionate]Zn(II) complex (4). Light green, yield 70%, FT-IR
Synthesis and in vitro biology of Co(II), Ni(II), Cu(II) and Zinc(II) complexes 275(KBr): 3424 (OH), 1733 (C‚O), 1599 (aromatic C‚C), 1137
(C–O); 1H NMR (DMSO-d6, 300 MHz,) d: 11.96 (s, 2H, 20-
OH), 4.64 (s, 2H, 40-OH), 8.34 (s, 2H, –CH‚), 6.36–7.30 (m,
16H, Ar-H); 13C NMR (DMSO-d6, 300 MHz,) d: 190.1 (s, C-
1, C‚O), 185.7 (s, C-3), 94.8 (s, C-2, –CH‚), 115.8 (s, C-10),
164.6 (s, C-20), 105.8 (s, C-30), 166.8 (s, C-40), 109.9 (s, C-50),
131.4 (s, C-60), 131.6 (s, C-100), 126.7 (s, C-200, C-600), 129.9 (s,
C-300, C-500), 129.8 (s, C-400). Anal. Calcd. for C30H22ZnO8
(M+): (575) C, 62.57; H, 3.85. Found: C, 62.60; 3.84.
6.2.2.5. Bis[1-(20,40-dihydroxyphenyl)-3-(200-chlorophenyl)-pro-
pane-1,3-dionate]Co(II) complex (5). Dark orange, yield
65%, FT-IR (KBr): 3429 (OH), 1739 (C‚O), 1601 (aromatic
C‚C), 1136 (C–O); 1H NMR (DMSO-d6, 300 MHz,) d: 11.90
(s, 2H, 20-OH), 4.63 (s, 2H, 40-OH), 8.33 (s, 2H, –CH‚), 6.45–
7.41 (m, 14H, Ar-H); 13C NMR (DMSO-d6, 300 MHz,) d:
190.4 (s, C-1, C‚O), 185.4 (s, C-3), 94.7 (s, C-2, –CH‚),
115.9 (s, C-10), 163.6 (s, C-20), 105.4 (s, C-30), 164.8 (s, C-40),
115.3 (s, C-50), 131.5 (s, C-60), 130.7 (s, C-100), 126.8 (s, C-200,
C-600), 129.8 (s, C-300, C-500), 128.6 (s, C-400). Anal. Calcd. for
C30H20Cl2CoO8 (M
+): (638) C, 56.45; H, 3.16. Found: C,
56.46; 3.19.
6.2.2.6. Bis[1-(20,40-dihydroxyphenyl)-3-(200-chlorophenyl)-pro-
pane-1,3-dionate]Ni(II) complex (6). Light yellow, yield 63%,
FT-IR (KBr): 3430 (OH), 1737 (C‚O), 1600 (aromatic
C‚C), 1138 (C–O); 1H NMR (DMSO-d6, 300 MHz,) d:
11.97 (s, 2H, 20-OH), 4.62 (s, 2H, 40-OH), 8.31 (s, 2H, –
CH‚), 6.43–7.48 (m, 14H, Ar-H); 13C NMR (DMSO-d6,
300 MHz,) d: 190.5 (s, C-1, C‚O), 185.7 (s, C-3), 94.6 (s, C-
2, –CH‚), 115.5 (s, C-10), 163.9 (s, C-20), 105.9 (s, C-30),
164.9 (s, C-40), 115.4 (s, C-50), 131.8 (s, C-60), 130.9 (s, C-100),
126.9 (s, C-200, C-600), 129.7 (s, C-300, C-500), 128.8 (s, C-400).
Anal. Calcd. for C30H20Cl2NiO8 (M
+): (638) C, 56.47; H,
3.16. Found: C, 56.49; 3.18.
6.2.2.7. Bis[1-(20,40-dihydroxyphenyl)-3-(200-chlorophenyl)-pro-
pane-1,3-dionate]Cu(II) complex (7). Brick red, yield 66%,
FT-IR (KBr): 3429 (OH), 1731 (C‚O), 1602 (aromatic
C‚C), 1134 (C–O); 1H NMR (DMSO-d6, 300 MHz,) d:
11.89 (s, 2H, 20-OH), 4.60 (s, 2H, 40-OH), 8.29 (s, 2H, –
CH‚), 6.43–7.40 (m, 14H, Ar-H); 13C NMR (DMSO-d6,
300 MHz,) d: 191.0 (s, C-1, C‚O), 185.9 (s, C-3), 94.7 (s, C-
2, –CH‚), 115.8 (s, C-10), 164.1 (s, C-20), 105.8 (s, C-30),
165.0 (s, C-40), 115.7 (s, C-50), 131.9 (s, C-60), 130.8 (s, C-100),
126.7 (s, C-200, C-600), 129.8 (s, C-300, C-500), 128.7 (s, C-400).
Anal. Calcd. for C30H20Cl2CuO8 (M
+): (642) C, 56.04; H,
3.14. Found: C, 56.08; 3.17.
6.2.2.8. Bis[1-(20,40-dihydroxyphenyl)-3-(200-chlorophenyl)-pro-
pane-1,3-dionate]Zn(II) complex (8). Greenish yellow, yield
63%, FT-IR (KBr): 3427 (OH), 1732 (C‚O), 1601 (aromatic
C‚C), 1131 (C–O); 1H NMR (DMSO-d6, 300 MHz,) d: 11.91
(s, 2H, 20-OH), 4.62 (s, 2H, 40-OH), 8.31 (s, 2H, –CH‚), 6.41–
7.39 (m, 14H, Ar-H); 13C NMR (DMSO-d6, 300 MHz,) d:
191.1 (s, C-1, C‚O), 186.0 (s, C-3), 94.8 (s, C-2, –CH‚),
115.9 (s, C-10), 164.2 (s, C-20), 105.7 (s, C-30), 165.2 (s, C-40),
115.9 (s, C-50), 131.7 (s, C-60), 130.6 (s, C-100), 126.8 (s, C-200,
C-600), 129.8 (s, C-300, C-500), 128.6 (s, C-400). Anal. Calcd. for
C30H20Cl2ZnO8 (M
+): (644) C, 55.88; H, 3.13. Found: C,
55.86; 3.15.7. Biological activity
7.1. Antibacterial activity (in vitro)
Two gram-positive (S. aureus ATCC 25923 and B. subtilis
ATCC 6633) and two gram-negative (E. coli ATCC 25922 and
P. aeruginosa ATCC 27853) bacteria were used as quality con-
trol strains. For determining anti-yeast activities of the com-
pounds, the following reference strains were tested: C. albicans
ATCC 10231 and C. glabrata ATCC 36583. Ampicillin trihy-
drate and Fluconazole were used as standard antibacterial and
antifungal agents, respectively. Solutions of the test compounds
and reference drugs were dissolved in DMSO at a concentration
of 20 mg ml1. The twofold dilution of the compounds and ref-
erence drug were prepared (20, 10, 5.0, 2.5, 1.25, 0.625, 0.31,
0.15, 0.07, 0.03, 0.019, 0.01, 0.005>) mg ml1. Antibacterial
activities of the bacterial strains were carried out inMuller–Hin-
ton broth (Difco) medium, at pH 6.9, with an inoculum of (1–
2) · 103 cells ml1 by the spectrophotometric method and an
aliquot of 100 ll was added to each tube of the serial dilution.
The chemical compounds-broth medium serial tube dilutions
inoculated with each bacterium were incubated on a rotary
shaker at 37 C for 24 h at 150 rpm.
7.2. Antifungal activity (in vitro)
All fungi were cultivated in Sabouraud Dextrose Agar
(Merck). The fungi inoculums were prepared in Sabouraud li-
quid medium (Oxoid) which had been kept at 36 C overnight
and was diluted with RPMI-1640 medium with L-glutamine
buffered with 3-[N-morpholino]-propansulfonic acid (MOPS)
at pH 7 to give a ﬁnal concentration of 2.5 · 103 cfu/ml. The
microplates were incubated at 36 C and read visually after
24 h, except for Candida species when it was at 48 h. The incu-
bation chamber was kept humid. At the end of the incubation
period, MIC values were recorded as the lowest concentrations
of the substances that gave no visible turbidity. The DMSO
diluents at a maximum ﬁnal concentration of 12.5% had no
effect on the microorganism’s growth.
7.3. Minimum inhibitory concentration (MIC)
The MICs of the chemical compound assays were carried out
as described by Clause (1989) with minor modiﬁcations. The
minimum inhibitory concentrations of the chemical com-
pounds were recorded as the lowest concentration of each
chemical compound in the tubes with no growth (i.e., no tur-
bidity) of inoculated bacteria.
7.4. Antioxidant assay
In vitro free radical scavenging activities of (L1)–(L2) and
(1)–(8) were evaluated by DPPH assay method. This method
is based on the reduction of a methanolic solution of the col-
ored DPPH radical. To a set of test tubes containing 3 ml of
methanol, 50 ll of DPPH reagent (2 mg/ml) was added. The
initial absorbance was measured. To this test tube, methanolic
solution of different test solutions (1 mg/ml) were added (10–
50 ll). Ascorbic acid (0.5 mg/ml) was added in the range of
10–25 ll. After 20 min, absorbance was recorded at 516 nm.
276 J. Sheikh et al.The experiment was performed in triplicate. The percentage
reduction in absorbance was calculated from the initial and
ﬁnal absorbance of each solution. Percentage scavenging of
DPPH radical was calculated using the formula:
% Scavenging of DPPH ¼ ½ðControl TestÞ=Control  100Acknowledgements
The authors are sincerely thankful to the Head, Department of
Chemistry, R.T.M. Nagpur University, Nagpur, for providing
necessary laboratory facilities and Director, SAIF, Chandi-
garh, for providing spectral data of the compounds.
References
Acton, N., Brossi, A., Newton, D.L., Sporn, M.B., 1980. Potential
prophylactic antitumor activity of retinylidene 1,3-diketones.
Journal of Medicinal Chemistry 23, 805–809.
Andrae, I., Bringhen, A., Bohm, F., Gonzenbach, H., Hill, T., Mulroy,
L., Truscott, T.A., 1997. A UVA ﬁlter (4-tert-butyl-40-meth-
oxydibenzoylmethane): photoprotection reﬂects photophysical
properties. Journal of Photochemistry and Photobiology B: Biol-
ogy 37, 147–150.
Ballhausen, C.J., Gray, H.B., 1963. p-Bonding in transition metal
complexes [1]. Inorganic Chemistry 2, 426–427.
Bennett, I., Broom, N.J.P., Cassels, R., Elder, J.S., Masson, N.D.,
O’Hanlon, P.J., 1999. Synthesis and antibacterial properties of b-
diketone acrylate bioisosteres of pseudomonic acid A. Bioorganic
and Medicinal Chemistry Letters 9, 1847–1852.
Brown, D.H., Lewis, A.J., Smith, W.E., Teape, J.W., 1980. Antiin-
ﬂammatory effects of some copper complexes. Journal of Medicinal
Chemistry 23, 729–734.
Castillo-Blum, S.E., Barba-Behrens, N., 2000. Coordination chemistry
of some biologically active ligands. Coordination Chemistry
Reviews 196, 3–30.
Clause, G.W., 1989. Understanding Microbes: A Laboratory Text-
book for Microbiology. W.H. Freeman and Company USA, New
York.
Crouse, G.D., McGowan, M.J., Boisvenue, R.J., 1989. Polyﬂouro 1, 3-
diketones as systemic insecticides. Journal of Medicinal Chemistry
32, 2148–2151.
Diana, G.D., Carabateas, P.M., Johnson, R.E., Williams, G.L.,
Pancic, F., Collins, J.C., 1978. Antiviral activity of some b-
diketones. 4. Benzyldiketones. In Vitro activity against both RNA
and DNA viruses. Journal of Medicinal Chemistry 21, 889–894.
Geary, W.J., 1971. The use of conductivity measurements in organic
solvents for the characterization of coordination compounds.
Coordination Chemistry Reviews 7, 81–122.
Lever, A.B.P., 1974. Charge transfer spectra of transition metal
complexes. Journal of Chemical Education 51, 612–616.Louie, A.Y., Meade, T.J., 1999. Metal complexes as enzyme inhibitors.
Chemical Reviews 99, 2711–2734.
Mandlik, P.R., More, M.B., Aswar, A.S., 2003. Synthesis, structural,
thermal and biological studies of Cr(III), Mn(III), Fe(III), VO(IV),
Zr(IV) and UO2(VI) Schiff base complexes. Indian Journal of
Chemistry – Section A 42, 1064–1067.
Marpadga, G., Reddy, G.S.R., Ganorkar, M.C., 1996. Preparation
and characterization of mixed-ligand dihydrazone complexes of
nickel(II). Transition Metal Chemistry 21, 101–104.
Ming, L.J., 2003. Structure and Function of ‘‘Metalloantibiotics’’.
Medicinal Research Reviews 23, 697–762.
Ming, L.J., Epperson, J.D., 2002. Metal binding and structure–activity
relationship of the metalloantibiotic peptide bacitracin. Journal of
Inorganic Biochemistry 91, 46–58.
Mishra, A.P., Khare, M., Gautam, S.K., 2002. Synthesis, physico-
chemical characterization, and antibacterial studies of some bioac-
tive Schiff bases and their metal chelates. Synthesis and Reactivity
in Inorganic and Metal-Organic Chemistry 32, 1485–1500.
Nishiyama, T., Shiotsu, S., Tsujita, H., 2002. Antioxidative activity
and active site of 1,3-indanediones with the b-diketone moiety.
Polymer Degradation and Stability 76, 435–439.
Pasto, D.J., 1969. Organic Structure Determination. Prentice Hall
International, London.
Ruiz, M., Perello, L., Ortiz, R., Castineiras, A., Maichle-Mossmer, C.,
Canton, E., 1995. Synthesis, characterization, and crystal structure
of [Cu(cinoxacinate)2]Æ2H2O complex: a square-planar CuO4 chro-
mophore. Antibacterial studies. Journal of Inorganic Biochemistry
59, 801–810.
Sheikh, J.I., Ingle, V.N., Juneja, H.D., 2009a. Synthesis of novel
antibacterial agents 1-(20,40-dihydroxy-50-chlorophenyl)-3-aryl-pro-
pane-1,3-diones. E-Journal of Chemistry 6, 705–712.
Sheikh, J.I., Ingle, V.N., Juneja, H.D., Munne, S.L., 2009b. Synthesis
of heterocyclic b-diketones. Indian Journal of Heterocyclic Chem-
istry 18, 333–336.
Silverstein, R.M., Webster, F.X., Kiemle, D.J., 2005. Spectrometric
Identiﬁcation of Organic Compounds. John Wiley & Sons.
Solomon, E.I., Sundaram, U.M., Machonkin, T.E., 1996. Multicopper
oxidases and oxygenase. Chemical Reviews 96, 2563–2605.
Tchertanov, L., Mouscadet, J.-F., 2007. Target recognition by
catechols and b-ketoenols: Potential contribution of hydrogen
bonding and Mn/Mg chelation to HIV-1 Integrase inhibition.
Journal of Medicinal Chemistry 50, 1133–1145.
Timerbaev, A.R., Hartinger, C.G., Aleksenko, S.S., Keppler, B.K.,
2006. Interactions of antitumor metallodrugs with serum proteins:
Advances in characterization using modern analytical methodol-
ogy. Chemical Reviews 106, 2224–2248.
Warad, D.U., Satish, C.D., Kulkarni, V.H., Bajgur, C.S., 2000.
Synthesis, structure and reactivity of zirconium Zr(IV), vanadium
(IV), cobalt (II), nickel (II) and copper (II) complexes derived from
carbohydrazide Schiff base ligands. Indian Journal of Chemistry –
Section A 39, 415–420.
